Showing results (71-80 of 761) with videos related to
Sort By:
Pageof 77
Pediatric Nephrology (Berlin, Germany)|November 26, 2015
Liver transplantation for aHUS: still needed in the eculizumab era?Rosanna Coppo, Roberto Bonaudo, R Licia Peruzzi, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody developmentMarta Todeschini, Monica Cortinovis, Norberto Perico, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2021
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practiceNine Knoers, Corinne Antignac, Carsten Bergmann, et al.Thrombosis and Haemostasis|March 1, 2005
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathiesMaria Piedad Ruiz-Torres, Federica Casiraghi, Miriam Galbusera, et al.Nephron|March 20, 2019
Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical AssociationElisabetta Valoti, Marta Alberti, Camillo Carrara, et al.Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.Frontiers in Medicine|November 23, 2020
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 VariantRossella Piras, Paraskevas Iatropoulos, Elena Bresin, et al.Transplantation|February 26, 2019
Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney TransplantationFederica Casiraghi, Marta Todeschini, Nadia Azzollini, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2022
Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 GlomerulopathyCristina Zanchi, Monica Locatelli, Domenico Cerullo, et al.Frontiers in Immunology|February 27, 2023
An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndromeSara Gastoldi, Sistiana Aiello, Miriam Galbusera, et al.Pageof 77